BRCA2 and breast cancer: For ChIP analysis, immuno-pulldown of the chromatin fragment by anti-FLAG antibody followed by end-point PCR using primers specific for the BRCA2 silencer revealed PRDX5A binding to the silencer in BC cells (Fig. 3e).